Study results on outcomes of ketamine intravenous therapy (KIT) show that it a rapid and robust treatment for depression, health care technology company Osmind and Public Benefit Corporation, said in a statement.
Read More at:
Copyright © PassionIT News.com
All right Reserved 2020